Advertisement

Kimbo Slice Negotiates Steroid Settlement for Failed Drug Test in Texas

Kevin “Kimbo Slice' Ferguson Dead at 42

Kevin “Kimbo Slice” Ferguson has reached a settlement with the Texas Department of Licensing and Regulation regarding a drug test that showed nandrolone, an anabolic steroid, and an elevated testosterone-to-epitestosterone ration in his system. The TDLR oversees regulation of the state's combat sports.

The drug test in question stems from Kimbo's fight with Dada 5000 (real name Dhafir Harris) at Bellator 149, which took place on Feb. 19 in Houston.

Though Kimbo initially was silent on the matter, following Bellator booking him for the main event of Bellator 158 on July 16 in London, his camp negotiated a settlement with the TDLR, according to an initial report by MMAJunkie.com. There was no explanation as to why the TDLR lessened Kimbo's punishment.

HOT TOPIC > Conor McGregor Blasts Nate Diaz, UFC 200, and Brock Lesnar

Kimbo reportedly waived the right to a hearing, instead agreeing to a $2,500 fine and the revocation of his license to fight in Texas. According to TDLR records, Kimbo's license was originally slated to expire on March 4, 2017. His fight with Dada 5000, initially a victory, was also changed to a no contest.

The settlement was a lessening of the original 90-day suspension, license revocation, and $4,000 fine.

Despite the license revocation, Bellator is moving ahead with Kimbo headlining the promotion's first event in London. He squares off with James Thompson in a rematch of their EliteXC fight from May of 2008, which Kimbo won.

There is no mixed martial arts regulatory body in England, so Bellator will instead use the International Sport Karate Association to oversee the event.

Follow MMAWeekly.com on Facebook, Twitter and Instagram